Clinical Research Directory
Browse clinical research sites, groups, and studies.
Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema
Sponsor: Jessa Hospital
Summary
Up to one out of five patients with breast cancer will develop lymphedema in the upper extremity after cancer treatment. Patients with breast cancer-related lymphedema (BCRL) suffer from pain, heaviness, tightness, and a decreased range of motion. Photobiomodulation therapy (PBMT) is a non-invasive therapy based on the application of visible and/or near-infrared light produced by a laser diode or a light-emitting diode. The scientifically proven biologic effects of PBM are improved wound healing, and a reduction in pain, inflammation, and oedema. Therefore, the aim of this study is to evaluate the effectiveness of PBMT on the management of BCRL.
Official title: Evaluating the Effectiveness of Photobiomodulation Therapy in the Management of Breast Cancer-Related Lymphedema: a Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
104
Start Date
2021-02-22
Completion Date
2028-02
Last Updated
2023-02-28
Healthy Volunteers
No
Interventions
Photobiomodulation therapy (PBMT)
The MLS M6 laser from ASA will be used to apply the laser therapy.
Manual Lymphatic drainage
Patients will receive twice weekly MLT executed by trained physiotherapist
Locations (2)
Hasselt University
Hasselt, Limburg, Belgium
Jessa Ziekenhuis
Hasselt, Limburg, Belgium